Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.
about
Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung CarcinomaAurora kinase targeting in lung cancer reduces KRAS-induced transformation.High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas.Neither the maximum tumor size nor solid component size is prognostic in part-solid lung cancer: to be ground-glass opacity or not to be, is that really the question?Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma.
P2860
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@en
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@nl
type
label
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@en
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@nl
prefLabel
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@en
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@nl
P2093
P2860
P356
P1476
Postrecurrence survival of sur ...... EGFR and KRAS mutation status.
@en
P2093
Hitoshi Igai
Izumi Takeyoshi
Jun Atsumi
Kimihiro Shimizu
Kyoichi Kaira
Masayuki Sugano
Mitsuhiro Kamiyoshihara
Noriaki Sunaga
Osamu Kawashima
Seiichi Kakegawa
P2860
P304
P356
10.3892/MCO.2013.237
P577
2013-12-31T00:00:00Z